NAFLD in type 1 diabetes: overrated or underappreciated?

Area of Science:

• Hepatology
• Endocrinology
• Cardiology

Background:

• Nonalcoholic fatty liver disease (NAFLD) is highly prevalent in Western countries, linked to obesity and type 2 diabetes.
• Insulin resistance (IR) and visceral adipose tissue accumulation are key contributors to NAFLD development.
• NAFLD can progress to severe liver conditions like cirrhosis and significantly increases cardiovascular morbidity and mortality.

Purpose of the Study:

• To investigate the prevalence and impact of NAFLD in individuals with type 1 diabetes (T1D).
• To explore the diagnostic challenges and epidemiological factors of NAFLD in the T1D population.
• To examine the association between IR, NAFLD, and both macrovascular and microvascular complications in T1D.

Main Methods:

• Review of current literature on NAFLD prevalence in T1D using ultrasonography and magnetic resonance imaging.
• Analysis of factors influencing NAFLD diagnosis and prevalence data in T1D.
• Exploration of the link between insulin resistance, NAFLD, and chronic complications in T1D patients.

Main Results:

• NAFLD prevalence in adults with T1D ranges from 19-31% by ultrasound and 2.1-18.6% by MRI, with variability due to study design and diagnostic methods.
• Individuals with T1D have a significantly higher risk of cardiovascular disease (CVD), with NAFLD potentially exacerbating this risk.
• Emerging data suggest NAFLD may increase the risk of microvascular complications in T1D by 2-3 fold.

Conclusions:

• NAFLD is a significant concern in the T1D population, with unclear prevalence and impact.
• Further research is needed to determine the independent contribution of NAFLD to cardiovascular events and microvascular complications in T1D.
• Developing reliable noninvasive screening tools for NAFLD in T1D is essential for early detection and management.